2 completed. 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Enzene Biosciences Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 3 Study to Compare Biosimilar Denosumab With Prolia® ENZ215, Prolia - Postmenopausal Osteoporosis | Phase 3 | Completed | Enzene Biosciences Ltd. | 504 | 2022-07-04 | 2026-02-10 |
| Study to Compare the Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, and Immunogenicity of Biosimilar Denosumab With Prolia® in Healthy Adult Male Volunteers ENZ215, EU Sourced Prolia, US Sourced Prolia - Healthy Male Subjects | Phase 1 | Completed | Enzene Biosciences Ltd. | 207 | 2022-01-10 | 2025-12-23 |
Osteoporosis, Postmenopausal (1)
Denosumab (1)
Bulgaria (2) · Poland (2) · Czechia (1) · Denmark (1) · Lithuania (1) · Serbia (1) · Spain (1)